Cargando…
Preclinical In Vivo Modeling of Pediatric Sarcoma—Promises and Limitations
Pediatric sarcomas are an extremely heterogeneous group of genetically distinct diseases. Despite the increasing knowledge on their molecular makeup in recent years, true therapeutic advancements are largely lacking and prognosis often remains dim, particularly for relapsed and metastasized patients...
Autores principales: | Imle, Roland, Kommoss, Felix K. F., Banito, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069549/ https://www.ncbi.nlm.nih.gov/pubmed/33918045 http://dx.doi.org/10.3390/jcm10081578 |
Ejemplares similares
-
Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications
por: Kommoss, Felix KF, et al.
Publicado: (2020) -
Preclinical Models of Visceral Sarcomas
por: Costa, Alice, et al.
Publicado: (2023) -
MODL-07. DNA methylation-based biobank of murine models for pediatric tumors
por: Zheng, Tuyu, et al.
Publicado: (2022) -
Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability
por: Benabdallah, Nezha S., et al.
Publicado: (2023) -
Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
por: Kolaric, Tea Omanovic, et al.
Publicado: (2023)